Aerobic Exercise for Type 1 Diabetes

Alberta Diabetes Institute, Edmonton, Canada
Targeting 2 different conditionsAerobic Exercise +2 moreN/ARecruitingResearch Sponsored by University of Alberta

Study Summary

This trial will test the effects of different types of exercise on blood sugar levels in people with diabetes.

Eligible Conditions
  • Type 1 Diabetes
  • Menopause

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below
You have been diagnosed with type 1 diabetes for at least one year.
You are physically able to do both aerobic exercises (like running or swimming) and resistance exercises (like weightlifting or push-ups).


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from 0 minutes to 45 minutes (beginning to the end of exercise/control) and then for 60 minutes after exercise
This trial's timeline: 3 weeks for screening, Varies for treatment, and from 0 minutes to 45 minutes (beginning to the end of exercise/control) and then for 60 minutes after exercise for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Blood glucose
Secondary outcome measures
carbohydrate supplementation
coefficient of variation (CV) of CGM glucose
frequency of hyperglycemia
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: All participantsExperimental Treatment3 Interventions
All participants will take part in all three testing conditions

Find a site

Who is running the clinical trial?

University of AlbertaLead Sponsor
864 Previous Clinical Trials
390,761 Total Patients Enrolled
Women and Children's Health Research Institute, CanadaOTHER
17 Previous Clinical Trials
24,920 Total Patients Enrolled

Media Library

Aerobic Exercise Clinical Trial Eligibility Overview. Trial Name: NCT05188027 — N/A
Type 1 Diabetes Research Study Groups: All participants
Type 1 Diabetes Clinical Trial 2023: Aerobic Exercise Highlights & Side Effects. Trial Name: NCT05188027 — N/A
Aerobic Exercise 2023 Treatment Timeline for Medical Study. Trial Name: NCT05188027 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are being sought for this experiment?

"Indeed, the online repository for clinical trials confirms that this investigation is presently recruiting. The trial was initially launched on November 16th 2021 and has continued to evolve until January 31st 2022 when it became open for enrollment of 20 subjects from a single medical facility."

Answered by AI

Is there any room for new participants in this research project?

"According to the information provided on, this research project is actively seeking participants with recruitment beginning on November 16th 2021 and the most recent update being published January 31st 2022."

Answered by AI

Could I join in this experiment as a volunteer?

"To partake in this medicinal experiment, participants must have diabetes and an autoimmune condition, as well as being between the ages of 45 to 75. In total 20 individuals are needed for the trial."

Answered by AI

Is eligibility for participation in the trial limited to those under 40 years of age?

"This investigation is enlisting participants aged 45-75."

Answered by AI

Who else is applying?

What state do they live in?
How old are they?
18 - 65
What site did they apply to?
Alberta Diabetes Institute
What portion of applicants met pre-screening criteria?
Met criteria

How responsive is this trial?

Typically responds via
~2 spots leftby Dec 2023